Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0013841017
Thu, 03.10.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Personnel
Lonza Nominates David Meline as Independent Board Member 03.10.2024 / 09:00 CET/CEST
David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors
Olivier Verscheure will not stand for re-election at the 2025 Annual General Meeting
Basel, Sw [ … ]
Tue, 01.10.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Acquisition
Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche 01.10.2024 / 16:45 CET/CEST
The Vacaville site is one of the largest biologics manufacturing facilities in the world
Acquisition extends Lonza’s US Biologics footprint with a significant presence on [ … ]
Tue, 24.09.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Partnership
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel) 24.09.2024 / 14:00 CET/CEST
Lonza to manufacture CASGEVY®, the world’s first CRISPR/Cas9 gene-edited cell therapy, for global commercial supply
CASGEVY® will be manufactured at Lonza [ … ]
Wed, 28.08.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Bond
Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds 28.08.2024 / 18:31 CET/CEST
Basel, Switzerland, 28 August 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of its dual tranche EUR 1.2 billion straight bonds. [ … ]
Thu, 25.07.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Personnel
Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members 25.07.2024 / 07:00 CET/CEST
Basel, Switzerland, 25 July 2024 - Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to [ … ]
Thu, 25.07.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Lonza delivered sales of CHF 3.1 billion, growing 1.8%1 CER
CHF 893 million CORE EBITDA resulted in a margin of 29.2%
Robust performance in CDMO business, with headwinds in the capsules business within the Capsules & Health Ingredients (CHI) division
Solid free cash flow at CHF 296 million
Group O [ … ]
Mon, 01.07.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): Personnel
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand 01.07.2024 / 07:00 CET/CEST
Wolfgang Wienand commences his tenure as Chief Executive Officer of Lonza Group
Albert M. Baehny will retire from Lonza Group following a transition period
Basel, Switzerland, 1 July 2024 – Wol [ … ]
Tue, 14.05.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Softer performance in Q1 2024, normalizing across H1 2024
Sustained commercial demand in CDMO business with initial signs of early-stage recovery
Key growth projects due to start in 2024 progressing in line with plan
Revised [ … ]
Tue, 14.05.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Softer performance in Q1 2024, normalizing across H1 2024
Sustained commercial demand in CDMO business with initial signs of early-stage recovery
Key growth projects due to start in 2024 progressing in line with plan
Revised [ … ]
Wed, 08.05.2024
Lonza Group AG
Lonza Group AG
/ Key word(s): AGMEGM
Lonza Announces Results of the 2024 Annual General Meeting – All Motions Proposed by Board of Directors Approved 08.05.2024 / 15:00 CET/CEST
Jean-Marc Huët was elected as Chairman of the Board of Directors
Shareholders re-elected all members of the Board of Directors standing for re-elect [ … ]